Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research: Workshop Summary

by InstituteofMedicine (Author), SteveOlson (Editor), RoundtableonTranslatingGenomic-BasedResearchforHea (Author), Adam C . Berger (Editor)

• New

  Paperback
  2010

  $27.54

  Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research.